Evidence map›Paper›PMID 40593079›Full record

ArticleScientific reports2025

Postzygotic mosaicism in SMC1A and the first reported case of a female with Cornelia de Lange syndrome.

Marta Gil-Salvador, Laura Trujillano, Cristina Lucia-Campos, Julia Del Rincón, Pilar Pamplona, María Arnedo, Beatriz Puisac, Íñigo Marcos-Alcalde, Paulino Gómez-Puertas, Feliciano J Ramos and 2 more

Abstract readCase Reports
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Marta Gil-SalvadorUnit of Clinical Genetics and Functional Genomics, Department of Pharmacology and Physiology, School of Medicine, University of Zaragoza, CIBERER and IIS-Aragon, 50009, Zaragoza, Spain.
Laura TrujillanoUnit of Clinical Genetics and Functional Genomics, Department of Pharmacology and Physiology, School of Medicine, University of Zaragoza, CIBERER and IIS-Aragon, 50009, Zaragoza, Spain.
Cristina Lucia-CamposUnit of Clinical Genetics and Functional Genomics, Department of Pharmacology and Physiology, School of Medicine, University of Zaragoza, CIBERER and IIS-Aragon, 50009, Zaragoza, Spain.
Julia Del RincónUnit of Clinical Genetics and Functional Genomics, Department of Pharmacology and Physiology, School of Medicine, University of Zaragoza, CIBERER and IIS-Aragon, 50009, Zaragoza, Spain.
Pilar PamplonaUnit of Clinical Genetics and Functional Genomics, Department of Pharmacology and Physiology, School of Medicine, University of Zaragoza, CIBERER and IIS-Aragon, 50009, Zaragoza, Spain.
María ArnedoUnit of Clinical Genetics and Functional Genomics, Department of Pharmacology and Physiology, School of Medicine, University of Zaragoza, CIBERER and IIS-Aragon, 50009, Zaragoza, Spain.
Beatriz PuisacUnit of Clinical Genetics and Functional Genomics, Department of Pharmacology and Physiology, School of Medicine, University of Zaragoza, CIBERER and IIS-Aragon, 50009, Zaragoza, Spain.
Íñigo Marcos-AlcaldeMolecular Modeling Group, Centro de Biología Molecular Severo Ochoa (CBM, CSIC-UAM), 28049, Madrid, Spain.
Paulino Gómez-PuertasMolecular Modeling Group, Centro de Biología Molecular Severo Ochoa (CBM, CSIC-UAM), 28049, Madrid, Spain.
Feliciano J RamosUnit of Clinical Genetics, Service of Paediatrics, Department of Paediatrics, School of Medicine, University Hospital Lozano Blesa, University of Zaragoza, CIBERER and IIS-Aragon, 50009, Zaragoza, Spain. framos@unizar.es.
Juan PiéUnit of Clinical Genetics and Functional Genomics, Department of Pharmacology and Physiology, School of Medicine, University of Zaragoza, CIBERER and IIS-Aragon, 50009, Zaragoza, Spain. juanpie@unizar.es.
Ana Latorre-PellicerUnit of Clinical Genetics and Functional Genomics, Department of Pharmacology and Physiology, School of Medicine, University of Zaragoza, CIBERER and IIS-Aragon, 50009, Zaragoza, Spain. alatorre@unizar.es.

Funding

Diputación General de Aragón-FEDER: European Social Fund B32_20RSpanish Government grant PID2021-126625OB-I00Spanish Ministry of Health-ISCIII PI23/01370Universidad de Zaragoza JIUZ2023-SAL-06
6 · The paper itself

Abstract

Postzygotic mosaicism (PZM) has been increasingly recognized in Cornelia de Lange syndrome (CdLS). However, it has been scarcely described when the genetic cause resides in SMC1A, an X-linked cohesin member implicated in approximately 5% of cases. Here, we report the first female patient with classic CdLS harboring a PZM variant in SMC1A and provide a comprehensive characterization of mosaicism in this gene. The identified PZM variant [SMC1A:NM_006306.3:c.2369 = /G > A; p.(Arg790Gln)], was detected in blood and buccal swab-derived DNA at around 30% allele frequency. Molecular dynamics simulations suggest that this mutation disrupts the elbow domain of SMC1A, potentially impairing cohesin function. Further delineation of phenotypes and genotypes associated with PZM variants in SMC1A reveals that, similar to constitutive variants, mosaic mutations are predominantly missense and distributed throughout the gene. Moreover, the phenotype of patients carrying mosaic variants is clinically indistinguishable from those with constitutive mutations, and purifying selection of the pathogenic variant in blood is suggested, as previously observed in NIPBL-related CdLS. However, this process may be more complex in SMC1A due to its X-linked nature. Our findings underscore the importance of high-sensitivity sequencing techniques for detecting mosaicism and highlight the complexity of X-linked mosaic variants in disease expressivity. Further functional studies and larger cohorts are crucial to improve genotype-phenotype correlations and diagnostics in CdLS.

Indexed as

Cell Cycle ProteinsChromosomal Proteins, Non-HistoneDe Lange SyndromeMosaicismFemaleHumansMutationPhenotypeStructural Maintenance of Chromosome Protein 1Cell Cycle ProteinsChromosomal Proteins, Non-HistoneStructural Maintenance of Chromosome Protein 1Cornelia de Lange syndromeDeep-sequencingPostzygotic mosaicismSMC1AX-linked inheritance

Identifiers

PMID40593079
PMCPMC12216401

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.